Key Financial Data Of Reporting Company

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7728785

Concept 2017-04-01 to
2017-12-31
As at
2017-12-31
2017-10-01 to
2017-12-31
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-10-01 to
2016-12-31
2016-04-01 to
2016-12-31
As at
2016-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
76,891,000,000 JPY
101,479,000,000 JPY
78,965,000,000 JPY
Ordinary profit (loss)
24,062,000,000 JPY
30,981,000,000 JPY
25,232,000,000 JPY
Net assets
111,604,000,000 JPY
102,655,000,000 JPY
98,854,000,000 JPY
Total assets
149,810,000,000 JPY
135,060,000,000 JPY
137,108,000,000 JPY
Basic earnings (loss) per share
416.06
148.57
536.70
159.93
437.85
Diluted earnings per share
Equity-to-asset ratio
0.745 xbrli:pure
0.760 xbrli:pure
0.721 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.